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Congenital haemolytic anaemias are inherited disorders caused by red blood cell
membrane and cytoskeletal protein defects, deviant hemoglobin synthesis and
metabolic enzyme deficiencies. In many cases, although the causing mutation
might be known, the pathophysiology and the connection between the particular
mutation and the symptoms of the disease are not completely understood.
Thus effective treatment is lagging behind. As in many cases abnormal red
blood cell cation content and cation leaks go along with the disease, by direct
electrophysiological measurements of the general conductance of red blood cells,
we aimed to assess if changes in the membrane conductance could be a
possible cause. We recorded whole-cell currents from 29 patients with different
types of congenital haemolytic anaemias: 14 with hereditary spherocytosis due
to mutations in α-spectrin, β-spectrin, ankyrin and band 3 protein; 6 patients
with hereditary xerocytosis due to mutations in Piezo1; 6 patients with enzymatic
disorders (3 patients with glucose-6-phosphate dehydrogenase deficiency, 1 patient
with pyruvate kinase deficiency, 1 patient with glutamate-cysteine ligase deficiency
and 1 patient with glutathione reductase deficiency), 1 patient with β-thalassemia
and 2 patients, carriers of several mutations and a complex genotype. While
the patients with β-thalassemia and metabolic enzyme deficiencies showed no
changes in their membrane conductance, the patients with hereditary spherocytosis
and hereditary xerocytosis showed largely variable results depending on the
underlying mutation.
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INTRODUCTION
Haemolytic anaemias, characterized by the abnormal breakdown
of red blood cells (RBCs), could be either acquired or inherited.
The latter are a diverse group of diseases that could be classified
based on the affected RBC component into membranopathies,
haemoglobinopathies, and enzymopathies (Dhaliwal et al., 2004).
Membranopathies are presented by hereditary spherocytosis
(HS), hereditary elliptocytosis (HE) and its aggravated form
pyropoikilocytosis (HPP) with defective structural membrane
and cytoskeletal proteins (Iolascon et al., 2003) and by the
largely heterogeneous group of stomatocytosis divided in a
most general way, but not exhaustively, into overhydrated
stomatocytosis (OHSt), cryohydrocytosis (CHC) and some
types of familial pseudohyperkalaemia (FP) (overhydrated
RBCs) and dehydrated stomatocytosis (DHSt) (hereditary
xerocytosis (HX)) (dehydrated RBCs) with defective ion channels
or transporters (Iolascon et al., 2003; Bruce et al., 2009).
Haemoglobinopathies are presented by β-thalassemia (Cao and
Galanello, 2010) and sickle cell disease (Ware et al., 2017) with
defective hemoglobin and enzymopathies are presented most
commonly by glucose-6-phosphate dehydrogenase deficiency
(G6PD) (Luzzatto et al., 2016) and pyruvate kinase deficiency
(PKD) (Zanella et al., 2005) but also by glutamate-cysteine
ligase (γ-glutamylcysteine synthetase) (GCL) deficiency (Ristoff
and Larsson, 1998) and glutathione reductase deficiency (van
Zwieten et al., 2014). Although much is known so far,
especially regarding the defective genes related to hereditary
haemolytic anaemias, there are still questions, whose answers
would lead to a much better understanding of the disease and
possibly to a more effective treatment. A recurrent issue is
if a changed membrane conductance, resulting from primary
mutated channels or secondary adapted ones, does contribute
to the various phenotypes. Most of the research has been done
on membranopathies, understandable, primarily on the ones
linked to mutations in ion channels or transporters such as
band 3 protein, Rh-associated glycoprotein (RhAG), the glucose
transporter GLUT1, Piezo1 and the Gardos channel (KCNN4)
and accompanied by abnormal RBC cation content and disrupted
volume homeostasis (Badens and Guizouarn, 2016). However,
although on most occasions, the RBC cation content linked to the
particular mutation has been extensively described (e.g., Stewart
et al., 2011 for R730C in band 3 protein or Fermo et al., 2017
for R352H in the Gardos channel) and the defective channels,
when known, expressed and studied in heterologous systems
(e.g., Glogowska et al., 2017 for a number of Piezo1 mutations)
with a few exceptions (Stewart et al., 2011; Andolfo et al., 2013;
Shmukler et al., 2014; Fermo et al., 2017; Rotordam et al.,
2018), direct electrophysiological measurements of membrane
conductance in mutated RBCs have been scarce.
Thus, within the CoMMiTMenT project, by direct RBCs
electrophysiological measurements in physiological solutions,
we aimed to investigate whether RBC membrane conductance
changes are accompanying HS due to mutations in the SPTA1
gene (coding for α-spectrin), SPTB (β-spectrin), ANK1 (ankyrin),
and SLC4A1 (band 3 protein); HX due to mutations in PIEZO1;
enzymatic disorders due to glucose-6-phosphate dehydrogenase
deficiency (G6PD), pyruvate kinase deficiency (PKD), glutamate-
cysteine ligase (γ-glutamylcysteine synthetase) (GCL) deficiency,
glutathione reductase deficiency and β-thalassemia.
MATERIALS AND METHODS
Patients
Patients diagnosed with different types of haemolytic anemia
were enrolled in the study after signing an informed consent.
Patients’ data were handled anonymously as outlined in the ethics
agreements. These agreements were approved by the Medical
Ethical Research Board (MERB) of the University Medical
Center Utrecht, the Netherlands (UMCU) under reference code
15/426M “Disturbed ion homeostasis in hereditary hemolytic
anemia” and by the Ethical Committee of Clinical Investigations
of Hospital Clinic, Spain (IDIBAPS) under reference code
2013/8436. Exclusion criteria were erythrocyte transfusion in the
past 90 days, age below 3 years and/or bodyweight lower than
18 kg. Blood from healthy control donors was anonymously
obtained using the approved medical ethical protocol of
07/125 Mini Donor Dienst, also approved by the MERB of
UMCU. The blood of the patient/patients and the healthy
donor anti-coagulated in heparin was shipped overnight from
the University Medical Center Utrecht (Utrecht, Netherlands)
or from Institut d’Investigacions Biomèdiques August Pi i
Sunyer/Hospital Clínic de Barcelona (Barcelona, Spain) to
Saarland University (Homburg, Germany) without additional
cooling as previously tested/simulated (Makhro et al., 2016).
All patients included in the study were genetically screened
for mutations by next-generation sequencing and diagnosed
with the following types of anemia: 14 patients were diagnosed
with HS (due to mutations in α-spectrin, β-spectrin, ankyrin
and band 3 protein), using golden standard techniques (EMA-
binding, osmotic gradient ektacytometry and osmotic fragility
test), 6 patients were diagnosed with hereditary xerocytosis (due
to mutations in Piezo 1), 6 patients had enzymatic disorders (3
patients with glucose-6-phosphate dehydrogenase deficiency, 1
patient with pyruvate kinase deficiency, 1 patient with glutamate-
cysteine ligase deficiency and 1 patient with glutathione reductase
deficiency), 1 patient had β-thalassemia and 2 were carriers
of several mutations and a complex genotype. The genotype
of the patients with HS, HX and of the two patients with
several mutations is given in Table 1. The numbering of
the patients and the corresponding healthy controls is kept
consistent with previous research (Hertz et al., 2017) studying the
same patient group.
Patch Clamp Analysis
Patch-clamp whole-cell measurements were performed with a
NPC-16 Patchliner (Nanion Technologies, Munich, Germany) as
previously described (Petkova-Kirova et al., 2018). Briefly, the
resistance of the chips was between 5 and 8 Mwith internal and
external solutions as follows (in mM): KCl 70, KF 70, NaCl 10,
HEPES 10, EGTA 3, CaCl2 1.2 to give free [Ca2+]i = 120 nM,
pH = 7.2 adjusted with KOH (internal) and NaCl 140, KCl 4,
MgCl2 5, CaCl2 2, D-glucose 5, HEPES 10, pH = 7.3 adjusted
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TABLE 1 | Patients overview.
Patient Clinical presentation Genotype Current compared to
transportation control
Current compared to
general control
P18.1 HS (α-spectrin) c.2755G > T (p.Glu919); αLELY Current ↑ Current ↑
P19.1 HS (α-spectrin) c.678G > A (p.Glu227fs); αLELY Current ↑ (not
statistically significant)
Current ↑
P15.1 HS (α-spectrin) c.4339-99C > T p.(?) No change No change
P20.1 HS (α-spectrin) c.[4339-99C > T; c.4347G > T] p.[(?;
Lys1449Asn)]
No change No change
P17.1 (splenectomized) HS (ankyrin) c.341C > T (p.Pro114Leu) Current ↓ ∗ No change
P17.2 HS (ankyrin) c.341C > T (p.Pro114Leu) Current ↓ ∗ No change
P11.1 HS (ankyrin) c.1943delC;c.2042delC
(p.Ala648fs;p.Ala681fs)
No change No change
P13.1 HS (ankyrin) c.344T > C (p.Leu115Pro) No change No change
P13.2 HS (ankyrin) c.344T > C (p.Leu115Pro) No change No change
P14.1 HS (ankyrin) c.2559-2A > G (splicing) No change No change
P10.1 HS (β-spectrin) c.2470C > T (p.Gln824) Outward current ↓↓ ∗ No change
P21.1 HS (β-spectrin) c.3449G > A (p.Trp1150) No change No change
P12.1 HS (band 3 protein) c.2348T > A (p.Ile783Asn) Current ↓ Inward current ↓
P16.1 HS (band 3 protein) c.2057 + 1G > A (splicing) No change No change
P11.1 SPTB c.154delC; p.Arg52fs + RHAG
c.808G > A; p.Val270Ile
Current ↑ Current ↑
P22.1 SPTA1 c.460_462dupTTG;
p.Leu154dup + PKLR c.1687G > A;
p.Gly563Ser + del3.7Kb HBA
Current ↑ Current ↑
Family 1
P51.3 HX c. 7367G > A p.Arg2456His No change No change
P51.4 HX c. 7367G > A p.Arg2456His No change No change
Family 2
P53.3 HX c. 6262C > G, p. Arg2088Gly No change No change
P53.2 HX c. 6262C > G, p. Arg2088Gly No change No change
Family 3
P50.2 HX c.1276T > C p. Cys426Arg No change Outward current ↑ ∗
Family 4
P52.1 HX c.7483_7488dupCTGGAG
p.2495_2496dupLeuGlu
Current ↓ Current ↓
P40.1 G6PD No change No change
P41.1 G6PD No change No change
P42.1 G6PD No change No change
P43.1 GCLD No change No change
P44.1 GRD No change No change
P45.1 PKD No change No change
P60.1 β-thalassemia No change No change
An upward arrow indicates an increase in current and a downward arrow indicates a decrease in current compared to the respective control. Two arrows label an extreme
change in the designated direction. Patients that show a change in current compared to both the transportation and a general control are given in bold. Asterisks mark
a deviation commented on in the main text. HS, hereditary spherocytosis; SPTB, β-spectrin; SPTA1, α-spectrin; HX, hereditary xerocytosis; GCLD, glutamate-cysteine
ligase deficiency; GRD, glutathione reductase deficiency; PKD, pyruvate kinase deficiency.
with NaOH (external). Gigaseals were considered successful if
exceeding 5 G. Gigaseal formation was facilitated by the use
of a seal enhancing solution as recommended by the Patchliner
manufacturer and containing (in mM): NaCl 80, KCl 3, MgCl2 10,
CaCl2 35, HEPES 10, pH = 7.3 adjusted with NaOH. Whole-cell
configuration was achieved by negative pressure suction pulses
between −45 mbar and −150 mbar and its formation judged by
the appearance of sharp capacitive transients. Whole-cell patch-
clamp recordings were conducted at room temperature using
voltage steps from −100 to 100 mV for 500 ms in 20 mV
increments at 5 s intervals, the holding potential being set at
−30 mV. Data are presented as current density (current divided
by capacitance, the latter estimated at the time of attaining the
whole-cell configuration and by using a short test pulse of 10 mV,
5 ms) and given as means± SEMs (n denotes number of cells and
N – number of patients). Significant differences are determined
based on an unpaired t-test and Welch’s correction for unequal
variances, when needed, with ∗ denoting p< 0.05.
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RESULTS
Whole-cell patch clamp measurements were performed to assess
possible differences in the membrane conductance of hereditary
anemia patients compared to healthy controls. Regarding
controls, we have compared the currents measured from the
RBCs of our patients once with their transportation control, i.e.,
currents measured from the RBCs of a healthy subject, whose
blood was delivered together with the blood of the patient, and
once with a general, pooled, control, i.e., currents measured from
the cells of all healthy subjects delivered throughout the study
(Table 1). The rational for this ‘double comparison’ is provided
in the discussion. Throughout the whole study, accordingly in
the manuscript, the abbreviation “P” stands for patient and “C”
stands for a control, healthy subject.
Hereditary Spherocytosis
Studied were patients with pathogenic mutations in SPTA1
(α-spectrin) (4 patients: P15.1, P18.1, P19.1, P20.1), SPTB
(β-spectrin) (2 patients: P10.1 and P21.1), ANK1 (ankyrin)
(6 patients: P11.1, P13.1, P13.2, P14.1, P17.1, and P17.2),
and SLC4A1 (band 3 protein) (2 patients: P12.1 and P16.1),
whose blood was delivered and, respectively, recorded from
together with the blood of a healthy subject (transportation
control). While no changes in the membrane conductance,
nor in membrane capacitance (0.69 pA/pF general control
vs. 0.63 pA/pF patients, p > 0.05; 0.65 pA/pF transportation
control vs. 0.63 pA/pF patients; p > 0.05) were revealed with
patients taken altogether (Figure 1), differences were observed
in certain patients’ groups as well as linked to particular
mutations Figures 3–5). Thus patients with mutations in SPTA1
(4 patients), showed no significant differences compared to
healthy controls delivered at the same days (4 healthy subjects)
(Figure 2A) or compared to a control pooled over all healthy
subjects included in the study (27 healthy subjects) (Figure 2B).
Capacitances were not different either (0.67 pA/pF patients vs.
0.68 pA/pF transportation control, p > 0.05; 0.67 pA/pF patients
vs. 0.69 pA/pF general control; p > 0.05). However, the two
patients, heterozygous for the SPTA1 mutation and carrying at
the same time an αLELY allele showed an increase in their inward
current (Figure 3). Figures 3Aa,Ba consider the particular SPTA1
αLELY patients [patient P18.1 (10 cells) and patient P19.1 (6
cells), respectively] vs. their transportation controls [C18 (6 cells)
and C19 (7 cells), respectively]. Figures 3Ab,Bb compare the
particular SPTA1 αLELY patients [P18.1 (10 cells) and P19.1 (6
cells) vs. a control pooled over all the cells of all healthy subjects
included in the study (175 cells)]. Figures 3Ac,Ad,Bc,Bd present
raw current traces recorded from the RBCs of a healthy subject
(Figures Ac,Bc), P18.1 (Figure 3Ad), and P19.1 (Figure 3Bd).
None of the two patients showed any difference in capacitance
compared with the general or with its transportation control
(0.59 pA/pF P18.1 vs. 0.74 pA/pF C18, p > 0.05; 0.59 pA/pF
P18.1 vs. 0.69 pA/pF general control, p > 0.05; 0.66 pA/pF P19.1
vs. 0.58 pA/pF C19, p > 0.05; 0.66 pA/pF P19.1 vs. 0.69 pA/pF
general control, p > 0.05). Furthermore, while HS patients with
underlying defects in ANK1 (6 patients) showed no significant
differences neither in their currents, nor in their capacitances
(0.67 pA/pF patients vs. 0.63 pA/pF transportation control,
p > 0.05; 0.67 pA/pF patients vs. 0.69 pA/pF general control;
p> 0.05) compared to the control group [Figure 4Aa considered
are the control healthy subjects delivered together with the
patients (4 healthy subjects) and Figure 4Ab considered are all
healthy subjects included in the study (27 healthy subjects)], there
was a family of patients P17.1 (splenectomized) and P17.2 (with
spleen) in whom an ANK1 mutation [c.341C> T (p.Pro114Leu)]
was associated with a decreased membrane conductance when
compared to their own controls (Figures 4Ba,Ca, respectively)
but not when compared to the pooled control of all healthy cells
(Figures 4Bb,Cb, respectively). Comparison of the capacitances
of P17.1 and P17.2 with their controls as well as the capacitance
of C17 with the general control is as follows: 0.67 pA/pF P17.1
vs. 0.525 pA/pF C17, p > 0.05; 0.67 pA/pF P17.1 vs. 0.69 pA/pF
general control, p > 0.05; 0.62 pA/pF P17.2 vs. 0.525 pA/pF
C17, p > 0.05; 0.62 pA/pF P17.2 vs. 0.69 pA/pF general control,
FIGURE 1 | Whole-cell recordings of ion currents from RBCs of healthy donors and HS patients. Compared are the I/V-curves of all HS patients (N = 14) with the I/V
curves of their transportation controls (N = 12) (A) and with the I/V curves of all healthy subjects delivered throughout the study (N = 27) (B), where N denotes
number of healthy subjects or HS patients. No changes were observed in capacitance either with the transportation (0.63 pA/pF patients vs. 0.65 pA/pF
transportation control; p > 0.05) or with the general control (0.63 pA/pF patients vs. 0.69 pA/pF general control; p > 0.05). Currents were elicited by voltage steps
from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs.
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FIGURE 2 | Whole-cell recordings of ion currents from RBCs of healthy donors and HS patients with α-spectrin mutations. Compared are the I/V-curves of all HS
patients with α-spectrin mutations (N = 4) with the I/V curves of their own transportation controls (N = 4) (A) and with the I/V curves of all healthy subjects delivered
throughout the study (N = 27) (B), where N denotes the number of healthy subjects or HS patients. No changes were observed in capacitance either with the
transportation (0.67 pA/pF patients vs. 0.68 pA/pF control; p > 0.05) or with the general control (0.67 pA/pF patients vs. 0.69 pA/pF control; p > 0.05). Currents
were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs.
FIGURE 3 | Whole-cell recordings of ion currents from RBCs of healthy donors and HS patients with α-spectrin mutations and carrying at the same time an αLELY
allele. Compared are the I/V curves of P18.1 (n = 10) with its own transportation control C18 (n = 6) (Aa) as well as with a general control (n = 175) (Ab), where n
denotes the number of cells from the patient or the controls. As examples raw current traces recorded from the RBCs of a healthy donor (C18), whose blood was
delivered together with the blood of P18.1 (Ac) and of patient P18.1 (Ad) are presented. Capacitances were not any different either with the transportation control
(0.59 pA/pF P18.1 vs. 0.74 pA/pF C18; p > 0.05) or with the general control (0.59 pA/pF patient vs. 0.69 pA/pF control; p > 0.05). Compared are the I/V curves of
P19.1 (n = 6) with its own transportation control C19 (n = 7) (Ba) as well as with a general control (n = 175) (Bb), where n denotes the number of cells from the
patient or the controls. As examples raw current traces recorded from the RBCs of a healthy donor (C19), whose blood was delivered together with the blood of
P19.1 (Bc) and of patient P19.1 (Bd) are presented. Capacitances were not any different either with the transportation control (0.66 pA/pF P19.1 vs. 0.58 pA/pF
C19; p > 0.05) or with the general control (0.66 pA/pF patient vs. 0.69 pA/pF general control; p > 0.05). Significant differences are determined based on an
unpaired t-test with ∗ representing p < 0.05. Mutations below patients numbers are designated as amino acid substitutions in the respective protein. The label αLELY
next to the mutation stands for the presence of an αLELY allele in the corresponding patient.
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FIGURE 4 | Whole-cell recordings of ion currents from RBCs of healthy donors and HS patients. Whole-cell recordings of ion currents from RBCs of healthy donors
and HS patients with ankyrin mutations (A–C). Compared are the I/V-curves of all HS patients with ankyrin mutations (N = 6) with the I/V curves of their own
transportation controls (N = 4) (Aa) and with the I/V curves of all healthy subjects delivered throughout the study (N = 27) (Ab), where N denotes the number of
healthy subjects or HS patients. No changes were observed in capacitance either with the transportation (0.67 pA/pF patients vs. 0.63 pA/pF transportation control;
p > 0.05) or with the general control (0.67 pA/pF patients vs. 0.69 pA/pF general control; p > 0.05). Compared are the I/V curves of P17.1 (n = 13) and its own
transportation control C17 (n = 6) (Ba) and the I/V curves of P17.2 (n = 11) with its own transportation control C17 (n = 6) (Ca), where n denotes the number of cells
from the patient or the control. (Bb,Cb) Compare the I/V curve of a general control based on currents recorded from all cells of all healthy subjects delivered
throughout the study (n = 175) with the I/V curve of P17.1 (n = 13) (Bb) and P17.2 (n = 11) (Cb) (n denotes number of cells).
(Continued)
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FIGURE 4 | Continued
Both patients 17.1 and 17.2 showed no differences in capacitance either with their transportation or with the general control (0.67 pA/pF P17.1 vs. 0.525 pA/pF
C17, p > 0.05; 0.67 pA/pF P17.1 vs. 0.69 pA/pF general control, p > 0.05; 0.62 pA/pF P17.2 vs. 0.525 pA/pF C17, p > 0.05; 0.62 pA/pF P17.2 vs. 0.69 pA/pF
general control, p > 0.05). However, a difference was uncovered between C17 and the general control (0.525 pA/pF C17 vs. 0.69 pA/pF general control; p < 0.05).
Whole-cell recordings of ion currents from RBCs of a healthy donor and a HS patient with band 3 protein mutation (D). Compared are the I/V curves of P12.1
(n = 17) with its own transportation control C12 (n = 7) (Da) as well as with a general control (n = 175) (Db), where n is the number of cells of the patient or the
controls. No changes were observed in capacitance either with the transportation (0.65 pA/pF P12.1 vs. 0.59 pA/pF C12; p > 0.05) or with the general control
(0.65 pA/pF P12.1 vs. 0.69 pA/pF general control; p > 0.05). Currents were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at
Vh = –30 mV. Data are expressed as mean current density ± SEMs. Significant differences are determined based on an unpaired t-test with ∗ representing p < 0.05.
Mutations below patients numbers are designated as amino acid substitutions in the respective protein.
p > 0.05; 0.525 pA/pF C17 vs. 0.69 pA/pF general control;
p < 0.05. Moreover a patient with a band 3 protein mutation
[SLC4A1 (2348T > A, Ile783Asn), P12.1 showed a decreased
current compared to its own, transportation, control (C12)
and to a pooled general control (Figures 4Da,b, respectively)].
No difference was found when the capacitance of the patient
was compared with that of the general or the transportation
control (0.65 pA/pF P12.1 vs. 0.59 pA/pF C12, p > 0.05;
0.65 pA/pF P12.1 vs. 0.69 pA/pF general control, p > 0.05).
Out of the two patients with SPTB mutations (P10.1 and P21.1)
(Figures 5A,Ba,b) one patient, P10.1, showed a significantly
different conductance compared to its transportation control C10
(Figure 5Ba). However, based on the fact that P10.1 showed
no difference with the general control (Figure 5Bb) and that
P21.1 showed no difference either with its transportation control
(Figure 5Aa) or with the general control (Figure 5Ab) as well
as on the fact that C10 is very different from the general, pooled
control (an outlier according to the Grubbs’ test) (Figure 5Bc),
we conclude that patients with β-spectrin mutations show no
changes in their current. Comparison of capacitances of P21.1
and P10.1 with their controls as well as the capacitance of C10
with the general control is as follows: 0.63 pA/pF P21.1 vs.
0.69 pA/pF C21, p > 0.05; 0.63 pA/pF P21.1 vs. 0.69 pA/pF
general control, p > 0.05; 0.68 pA/pF P10.1 vs. 0.82 pA/pF
C10, p < 0.05; 0.68 pA/pF P10.1 vs. 0.69 pA/pF general control,
p> 0.05; 0.82 pA/pF C10 vs. 0.69 pA/pF general control; p< 0.05.
C10 shows a significantly increased capacitance compared to
P10.1 as well as to the general control.
Two additional patients P11.1 and P22.1, carriers of
several mutations and a complex genotype (SPTB c.154delC;
p.Arg52fs + RHAG c.808G > A; p.Val270Ile and SPTA1
c.460_462dupTTG; p.Leu154dup + PKLR c.1687G > A;
p.Gly563Ser + del3.7Kb HBA, respectively) show an increase
in their currents (Figures 6A,B, respectively). The capacitances
of none of the patients show any difference with their controls
(0.59 pA/pF P11.1 vs. 0.66 pA/pF C11, p > 0.05; 0.59 pA/pF
P11.1 vs. 0.69 pA/pF general control, p > 0.05; 0.61 pA/pF P22.1
vs. 0.64 pA/pF C22, p > 0.05; 0.61 pA/pF P22.1 vs. 0.69 pA/pF
general control, p> 0.05).
Hereditary Xerocytosis
Considered were 4 families with mutations in the PIEZO1
gene (Family 1 with patients P51.3 and P51.4; Family 2 with
P53.2 and P53.3; Family 3 with P50.2 and Family 4 with P52.1),
whose blood was delivered and recorded from, together with
the blood of a healthy subject (transportation control) (C51,
C53, C50, and C52, respectively). No changes in the membrane
conductance or in the membrane capacitance were revealed
with patients taken altogether (Figure 7A) as well as in two
families (Family1 (P51.3 and P51.4) and Family 2 (P53.2
and P53.3) compared both to their transportation controls
and to a general control (Figures 7Ba,b,Ca,b, respectively).
However, P50.2 (Family 3), although showing no difference
with its transportation control (Figure 8Aa), demonstrated
increased conductance compared to the general, pooled, control
(Figure 8Ab). There was also a family (Family 4 with P52.1)
in which the Piezo1 mutation (c.7483_7488dupCTGGAG
p.2495_2496dupLeuGlu) was associated with a decreased
conductance compared both to the transportation and to
the general, pooled, control (Figures 8Ba,b, respectively).
Both Family 3 and Family 4 did not show a change in
their capacitance compared to their transportation or to
the general control.
Enzymopathies
Considered were 6 patients with enzymatic disorders as
follows: 3 patients with glucose-6-phosphate dehydrogenase
deficiency (P40.1, P41.1, and P42.1), 1 patient with pyruvate
kinase deficiency (P45.1), 1 patient with glutamate-cysteine
ligase deficiency (P43.1) and 1 patient with glutathione
reductase deficiency (P44.1). None of the patients showed
a difference in their membrane conductance or capacitance
compared to a general or their own transportation
control (Figures 9, 10).
Beta-Thalassemia
The patient (P60.1) with β-thalassemia showed no difference
in its membrane conductance or membrane capacitance
either compared to a general or to its own, transportation,
control (Figure 11).
DISCUSSION
Hereditary Spherocytosis
Electrophysiological measurements revealed additional new
characteristics for HS and confirmed the heterogeneity of the
disease showing that changes in membrane conductance are not
an overall feature of the disease but depend on the particular,
specific mutation (Huisjes et al., unpublished).
Interesting is that out of the many patients with SPTA1
mutations it is the two patients carrying a SPTA1 αLELY
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FIGURE 5 | Whole-cell recordings of ion currents from RBCs of healthy donors and HS patients. Whole-cell recordings of ion currents from RBCs of healthy donors
and HS patients with β-spectrin mutations (A,Ba,b). Compared are the I/V curves of P21.1 (n = 8) with its own transportation control C21 (n = 5) (Aa) as well as with
a general control (n = 175) (Ab). Compared are the I/V curves of P10.1 (n = 3) with its own transportation control C10 (n = 6) (Ba) as well as with a general control
(n = 175) (Bb). (Bc) Compares the I/V curve of the transportation control of P10.1, C10 (n = 6) with a general control (n = 175), where n denotes the number of cells.
Currents were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs.
Significant differences are determined based on an unpaired t-test with ∗ representing p < 0.05. Mutations below patients numbers are designated as amino acid
substitutions in the respective protein.
allele that show a change in their membrane conductance:
an increase in their inward current. This holds true
for P18.1 vs. its own transportation control and vs. the
general control of 175 cells and also for patient P19.1
vs. the pooled control. Although not reaching statistical
significance the inward current of P19.1 compared to its
own transportation control is also increased. Evident are
the large variations within the cells of the patients for
both patient P18.1 and P19.1 but especially for P19.1. This
might explain why the difference in the inward current
between P19.1 and its transportation control does not reach a
statistical significance.
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FIGURE 6 | Whole-cell recordings of ion currents from RBCs of healthy donors and patients, carriers of several mutations and a complex genotype. Compared are
the I/V curves of P11.1 (n = 11) with its own transportation control C11 (n = 13) (Aa) as well as with a general control (n = 175) (Ab). Compared are the I/V curves of
P22.1 (n = 8) with its own transportation control C22 (n = 5) (Ba) as well as with a general control (n = 175) (Bb), where n denotes the number of cells. Currents were
elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs. Significant
differences are determined based on an unpaired t-test with ∗ representing p < 0.05. Mutations below patients numbers are designated as amino acid substitutions
in the respective proteins. Additionally to having an α-spectrin mutation P22.1 is PK deficiency carrier as well as an α-thalassemia carrier.
Allele αLELY is a common polymorphic allele and its presence
in humans is by itself asymptomatic. The αLELY allele, however,
plays the role of an exacerbating factor when it occurs in
trans to an α-spectrin mutation resulting in a disastrously
weak spectrin network (Viel and Branton, 1996; Iolascon et al.,
2003). This is because, due to their reduced ability to form
dimers, α chains from αLELY alleles are underrepresented in
the mature RBC cytoskeleton. Accordingly underrepresented are
any spectrin mutations found on the same allele and in turn
overrepresented if found on the opposite allele (Wilmotte et al.,
1997). How a destabilized cytoskeleton might have an effect
on membrane conductance is a subject of speculations but as
the RBC membrane has little structural integrity without the
support of an intact and steady protein scaffold below, it might
be that conformational changes influence the proper functioning
of channels and lead to increased membrane conductance.
Noteworthy, in many cases, aggravating conditions such as
an αLELY allele or a superimposed erythrocytic defect lead to an
enhanced membrane conductance and a leaky cell. Thus P11.1
with a mutation in β-spectrin as well as a mutation in RHAG and
P22.1 with a mutation in α-spectrin as well as being a pyruvate
kinase deficiency and a thalassemia carrier show an increase
both in their inward and outward current. While in the case
of P22.1 such an increase cannot be straightforwardly explained
as neither thalassemia nor pyruvate kinase deficiency alone give
any change in conductance, P11.1 is particularly interesting.
The Rh-associated glycoprotein (RhAG) coded by the RHAG
gene, together with the RhD and RhCcEe proteins, is a major
component of the Rh blood group system. It is essential for
assembly of the Rh protein complex in the RBC membrane and
for expression of the Rh antigens (Avent and Reid, 2000). The
exact function of RhAG is not completely understood but it is
suggested to be involved in RBC gas exchange as it promotes
transmembrane NH3 transport (additionally NH4+) (Bakouh
et al., 2006) as well as facilitates CO2 membrane permeation
(Endeward et al., 2008). More interesting is, however, that RhAG
can act as a pore for monovalent cations (Na+, K+, and Li+)
and RHAG point mutations leading to Ile61Arg and Phe65Ser
substitutions result in massively increased permeabilities for K+
and Na+ and to overhydrated stomatocytosis (Bruce et al., 2009).
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FIGURE 7 | Whole-cell recordings of ion currents from RBCs of healthy donors and HX patients. Compared are the I/V-curves of all HX patients (N = 6) with the I/V
curves of their own transportation controls (N = 4) (Aa) and with the I/V curves of all healthy subjects delivered throughout the study (N = 27) (Ab), where N denotes
the number of healthy subjects or HX patients. No changes were observed in capacitance either with the transportation (0.725 pA/pF patients vs. 0.71 pA/pF
transportation control; p > 0.05) or with the general control (0.725 pA/pF patients vs. 0.69 pA/pF general control; p > 0.05). Compared are the I/V curves of P51.3
and P51.4 pooled together (Family 1) (n = 22) with their own transportation control C51 (n = 7) (Ba) and the I/V curves of P53.2 and P53.3 pooled together (Family 2)
(n = 27) with their own transportation control C53 (n = 9) (Ca), where n denotes the number of cells from the patients or the controls. (Bb,Cb) Compare the I/V curve
of a general control based on currents recorded from all cells of all healthy subjects delivered throughout the study (n = 175) with the I/V curve of P51.3 and P51.4
pooled together (n = 22) (Bb) and P53.2 and P53.3 pooled together (n = 27) (Cb) (n denotes number of cells). P51.3 and P51.4 pooled together (Family 1) and
P53.2 and P53.3 pooled together (Family 2) did not show a difference in their capacitance compared to the general or transportation control (0.69 pA/pF P51.3 and
P51.4 vs. 0.72 pA/pF C51, p > 0.05; 0.69 pA/pF P51.3 and P51.4 vs. 0.69 pA/pF general control, p > 0.05; 0.75 pA/pF P53.2 and P53.3 vs. 0.71 pA/pF P53,
p > 0.05; 0.75 pA/pF P53.2 and P53.3 vs. 0.69 pA/pF general control, p > 0.05) Currents were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV
increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs. Significant differences are determined based on an unpaired t-test with ∗
representing p < 0.05. Mutations below patients numbers are designated as amino acid substitutions in the respective protein.
Expression of the mutated RhAGs in xenopus oocytes confirms
the large monovalent leaks imposed by the mutations and
modeling studies correlate those leaks with possibly widening
the pore structures permitting passive diffusion of Na+ and
K+ (Bruce et al., 2009). Mutation c.808G > A in P11.1 with a
substitution Val270Ile residing in the 5th endoloop of RhAG
(Huang et al., 1999) although not linked to overhydrated
stomatocytosis relates to the Rhnull syndrome accordingly
characterized by varying degrees of chronic haemolytic anemia
and spherostomatocytosis (Nash and Shojania, 1987). Without
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FIGURE 8 | Whole-cell recordings of ion currents from RBCs of healthy donors and HX patients. Compared are the I/V curves of P50.2 (n = 14) with its own
transportation control C50 (n = 7) (Aa) as well as with a general control (n = 175) (Ab). Comparison of capacitance of P50.2 with control capacitances gave no
difference with the general or the transportation control (0.73 pA/pF P50.2 vs. 0.80 pA/pF transportation control; p > 0.05; 0.73 pA/pF P50.2 vs. 0.69 pA/pF general
control; p > 0.05). Compared are the I/V curves of P52.1 (n = 20) with its own transportation control C52 (n = 11) (Ba) as well as with a general control (n = 175)
(Bb), where n denotes the number of cells. No changes were observed in capacitance either with the transportation (0.75 pA/pF P52.1 vs. 0.62 pA/pF C52;
p > 0.05) or with the general control (0.75 pA/pF P52.1 vs. 0.69 pA/pF general control; p > 0.05). Currents were elicited by voltage steps from –100 to 100 mV for
500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs. Significant differences are determined based on an unpaired
t-test with ∗ representing p < 0.05. Mutations below patients numbers are designated as amino acid substitutions in the respective protein.
knowing the mechanism that might relate mutation RHAG
c.808G > A (or the complex defect c.808G > A+SPTB
c.154delC) to changes in the RBC membrane conductance,
P11.1 has been described with having less K+ in the
plasma than its transportation control yet more than a non-
transported normal control and a much increased activity
of its Na+/K+ pump (Huisjes et al., unpublished). Thus, it
could well be that a possibly increased K+ leak underlined
by the detected increased membrane conductance triggers
compensatory changes, namely enhanced ion pumping that
might explain the partially compensated K+ leak (i.e., that K+
in the plasma of the patient is less than K+ in the plasma
of its transportation control). This is in line with observations
that haemolytic diseases showing increased non-Na+/K+ pump
and non-NaK2Cl cotransport, K+ fluxes [ouabain- (an inhibitor
of the Na+/K+ pump) and bumetanide-(an inhibitor of the
NaK2Cl cotransport) resistant K+ fluxes] are accompanied
by increased Na+/K+ pump fluxes (ouabain- sensitive fluxes)
(Stewart, 2004).
Not always, however, a resulting changed membrane
conductance is manifested as an increase in current. A patient
(P12.1) with a mutation in band 3 protein shows a decrease in
current and, although counterintuitive, also accompanied by a
significant loss of K+ from the RBC.
The major function of band 3 protein is of an anion
transporter exchanging a bicarbonate for a chloride ion across
the RBC plasma membrane thus ensuring efficient removal of
CO2 from tissues (Guyton and Hall, 2006). However, data in
the literature show that point mutations resulting in single
amino acid substitutions cause Na+ and K+ leaks with anion
transport activity either maintained or abolished depending
on the mutation (Bruce et al., 1993, 2005; Salhany et al.,
1995; Stewart et al., 2010, 2011). Those mutations causing
predominantly stomatocytosis but also spherocytosis (Arakawa
et al., 2015) have been suggested to induce monovalent cation
leaks in one of 3 possible ways: (i) converting the anion
exchanger in a non-selective cation conductor, (ii) inducing
cation conductance in a still functioning exchanger and (iii)
causing the anion exchanger to stimulate endogenous cation
transporters (Badens and Guizouarn, 2016). The latter has
been shown in heterologous expression systems (Stewart et al.,
2010) as well as in RBCs (H734R) (Bogdanova et al., 2009).
It could indeed be that band 3 protein is engaged in complex
interactions modulating cation permeability pathways (both
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FIGURE 9 | Whole-cell recordings of ion currents from RBCs of healthy donors and patients with enzymopathies (glucose-6-phosphate dehydrogenase deficiency
and pyruvate kinase deficiency). Compared are the I/V-curve of all glucose-6-phosphate dehydrogenase deficiency patients (N = 3) with the I/V curve of their own
transportation controls (N = 3) (Aa) and with the I/V curve of all healthy subjects delivered throughout the study (N = 27) (Ab), where N denotes the number of
healthy subjects or patients. Capacitance of the three patients P40.1, P41.1, P42.1 was not any different from that of the controls (0.62 pA/pF
P40.1 + P41.1 + P42.1 vs. 0.68 pA/pF C40 + C41 + C42, p > 0.05; 0.62 pA/pF P40.1 + P41.1 + P42.1 vs. 0.69 pA/pF general control, p > 0.05). Compared are
the I/V-curve of all glucose-6-phosphate dehydrogenase deficiency patients cells (n = 27) with the I/V curve of all transportation control cells (n = 22) (Ba) as well as
with a general control (n = 175) (Bb), where n denotes the number of cells. Compared are the I/V curves of P45.1 (“PK” below the patient number stands for
pyruvate kinase deficiency) (n = 15) with its own transportation control C45 (n = 5) (Ca) as well as with a general control (n = 175) (Cb). No changes were observed
in capacitance either with the transportation (0.72 pA/pF P45.1 vs. 0.68 pA/pF C45; p > 0.05) or with the general control (0.72 pA/pF P45.1 vs. 0.69 pA/pF general
control; p > 0.05). Currents were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean
current density ± SEMs.
channels and transporters) and that mutations changing its
conformation or its availability in the membrane might lead to
multifaceted effects either increasing or decreasing membrane
conductance (both of which with the detrimental result of
disturbing RBC ion homeostasis). In line is a study showing
kidney band 3 protein interaction with nephrin (Wu et al.,
2010). The intracellular domain of nephrin interacts with
TRPC6, believed to be present in erythrocytes (Foller et al., 2008;
Danielczok J. et al., 2017) suggesting a possible functional link
between band 3 protein and TRPC6 in erythrocytes as well.
While no changes in cation channel activity (not an increase
either, regardless of the reported substantially elevated cation
leak) have been detected in band 3 protein R730C RBCs
[as measured by on-cell patch-clamp, (Stewart et al., 2011)]
as well as in band 3 protein H734R RBCs [as judged by
membrane potential changes, (Bogdanova et al., 2009)], it could
be that each mutation alters in a different way endogenous
permeability pathways.
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FIGURE 10 | Whole-cell recordings of ion currents from RBCs of healthy donors and patients with enzymopathies. Compared are the I/V curves of P43.1 (GCLD
below the patient number stands for glutamate-cysteine ligase deficiency) (n = 6) with its own transportation control C43 (n = 5) (Aa) as well as with a general control
(n = 175) (Ab). No changes were observed in capacitance either with the transportation (0.64 pA/pF P43.1 vs. 0.65 pA/pF C43; p > 0.05) or with the general control
(0.64 pA/pF P43.1 vs. 0.69 pA/pF general control; p > 0.05). Compared are the I/V curves of P44.1 (GRD below the patient number stands for glutathione
reductase deficiency) (n = 9) with its own transportation control C44 (n = 5) (Ba) as well as with a general control (n = 175) (Bb), where n denotes the number of
cells. No changes were observed in capacitance either with the transportation (0.76 pA/pF P44.1 vs. 0.65pA/pF C44; p > 0.05) or with the general control
(0.76 pA/pF P44.1 vs. 0.69 pA/pF general control; p > 0.05). Currents were elicited by voltage steps from −100 to 100 mV for 500 ms in 20 mV increments at
Vh = −30 mV. Data are expressed as mean current density ± SEMs.
FIGURE 11 | Whole-cell recordings of ion currents from RBCs of healthy donors and a patient with β-thalassemia. Compared are the I/V curves of P60.1 (n = 12)
with its own transportation control C60 (n = 5) (A) as well as with a general control (n = 175) (B). No changes were observed in capacitance either with the
transportation (0.72 pA/pF P60.1 vs. 0.64 pA/pF C60; p > 0.05) or with the general control (0.72 pA/pF P60.1 vs. 0.69 pA/pF general control; p > 0.05). Currents
were elicited by voltage steps from –100 to 100 mV for 500 ms in 20 mV increments at Vh = –30 mV. Data are expressed as mean current density ± SEMs.
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Regarding mutation Ile783Asn of patient P12.1, it is not in
the cytoplasmic half of the core domain of band 3 protein,
where most of the mutations causing stomatocytosis are
(Arakawa et al., 2015), yet it is very close to and in the same
transmembrane domain (TM 12) as another mutation, namely
Gly796Arg, also triggering stomatocytosis (Arakawa et al., 2015).
According to (Huisjes et al., unpublished) mutation Ile783Asn
is accompanied by increased Na+-K+-ATPase activity, a referral
to stomatocytosis, yet by an osmoscan curve with a typical HS
pattern and extremely low eosin-5-maleimide (EMA) staining
(61%), likely reflecting strongly reduced copy numbers of band
3 protein, a referral to spherocytosis. (EMA-binding on RBCs
involves the ε-NH group of lysine at position 430 from band
3 protein (Nicolas et al., 2003) and is experimentally found to
correlate with band 3 protein expression on RBCs (Huisjes et al.,
2018). Thus the question whether it is the unavailability of band
3 protein or a possible structural and conformational change that
causes the decreased outward current, remains open.
In our study, as outlined in the Results section, we have
compared the currents measured from the RBCs of our
patients once with their transportation control, i.e., currents
measured from the RBCs of a healthy subject, whose blood
was delivered together with the blood of the patient, and
once with a general control, i.e., currents measured from the
cells of all healthy subjects delivered throughout the study.
Inevitably a question comes up, especially when there are
differences in the comparisons with the two controls, which is
the more appropriate one. Whereas, undoubtedly, considering
the transportation control, allows us to take into account
the particular transportation conditions such as temperature,
vibration intensity and shipment duration, it has limitations.
Such limitations are the low number of measured cells but mostly
the fact that the control subject, although judged healthy, might
not be a representative control. Thus in the case with C17, the
control for patients P17.1 and P17.2, the averaged capacitance
of C17 RBCs (0.53 pA/pF) is statistically significantly smaller
than the averaged capacitance of the RBCs of the general control
(0.69 pA/pF). This in turn results in an increased current density
(current divided by capacitance) for the transportation control
which might explain the observed difference of P17.1 and P17.2
compared to C17 but not to the general control (Figures 4B,C).
With C10, the control of P10.1, the situation is even more
extreme, as, even though the averaged capacitance of the RBCs
of the transportation control is higher compared to the averaged
capacitance of the general control, which results in a lower
current density, the current density still remains much higher
than the one of the general control. The appearance of the I/V
curve is also very different with the reversal potential being much
shifted to the more negative values compared to the general
control (Figure 5Bc). The above mentioned limitations could
be avoided by considering the general control which, due to
the high number of cells, is balancing (smoothing out) the
effect of a healthy but unrepresentative subject and is close
to an ‘ideal’ control. At the same time what is an advantage
of the general control is simultaneously a disadvantage as it
‘balances’ also the specific transportation effects on the samples.
A way out of accidentally coming across a non-representative
healthy subject is using the blood of several healthy subjects as a
transportation control or, even better, the blood of several healthy
relatives. A further problem, however, is that transportation
could have different effects on the patient and on the control.
This problem could be avoided by avoiding transportation itself,
whenever possible.
Hereditary Xerocytosis
Piezo 1 is a mechanically activated cation channel (Coste
et al., 2010, 2012), which is permeable to monovalent cations
(PK > PCs ∼= PNa > PLi) and to most divalent cations like
Ba2+, Ca2+, and Mg2+, but not Mn2+ (Gnanasambandam
et al., 2015). Expressed in many tissues like kidney, lung and
urinary bladder (Coste et al., 2010; Miyamoto et al., 2014),
Piezo 1 has been detected in the plasma membrane of RBCs,
e.g., by mass spectroscopy and immunologically (Zarychanski
et al., 2012; Andolfo et al., 2013; Kaestner and Egée, 2018).
A major role of Piezo1 channels in RBCs is in volume
regulation and mutations in the channel have been linked to
HX, a dominantly inherited haemolytic anemia, characterized
by decreased K+ and increased Na+ RBCs content, as well as
dehydration resulting in increased mean corpuscular hemoglobin
concentrations (MCHC), a leftward shift of the osmotic gradient
ektacytometry curve and increased osmotic resistance of the
RBCs (Gallagher, 2013; Shmukler et al., 2014; Glogowska
and Gallagher, 2015; Andolfo et al., 2016). Disease clinical
manifestations are variable and may include mild to moderate
haemolysis, perinatal edema and non-immune hydrops fetalis
that spontaneously resolve, thrombosis, pseudohyperkalemia and
sometimes severe iron overload in the course of the disease
(Gallagher, 2013; Glogowska and Gallagher, 2015; Andolfo et al.,
2016). Out of the four mutations in our study [R2456H (P51.3
and P51.4), R2088G (P53.3 and P53.2), C426R (P50.2), and
E2496ELE (P52.1)], three (R2456H, R2088G, and E2496ELE)
are known and have been extensively characterized including
expression of the mutant Piezo1 channel in heterologous systems
and characterization of the channel activity (Zarychanski et al.,
2012; Albuisson et al., 2013; Andolfo et al., 2013; Bae et al.,
2013; Sandberg et al., 2014; Shmukler et al., 2014; Glogowska
et al., 2017). Two of the mutations, R2456H and E2496ELE,
among the most common ones found in typical HX patients
(Zarychanski et al., 2012; Albuisson et al., 2013; Andolfo et al.,
2013; Shmukler et al., 2014), are in the C-terminal region,
part of the pore module of Piezo1 (Coste et al., 2015; Ge
et al., 2015). Those mutations do not alter the sensitivity of
the channel to mechanical stimulation but cause considerable
increase in the inactivation time constant thus giving rise to
an increased channel activity in response to a given mechanical
stimulus (Albuisson et al., 2013; Glogowska et al., 2017). Could
an increased channel activity lasting only for the duration
of a short mechanical stimulus explain the ion disbalance
observed in HX? A possible answer is that during their
circulation in the vascular system RBCs are under constant
mechanical stress squeezing in capillaries and in the tiny slits
of the spleen undergoing numerous rounds of mechanical
stimulation with Piezo1 activation (Danielczok J.G. et al., 2017)
and, in the case of Piezo1 prolonged inactivation, not being
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capable of replenishing their ions. However, it is also likely
that slowing of inactivation could potentially cause a slight
increase in a basal Piezo1 activity (independent of mechanical
stimulation) (Albuisson et al., 2013). This is supported by the
study of (Andolfo et al., 2013), which demonstrates spontaneous
ion channel activity in R2456H patient RBCs, blocked by
GsMTx-4 and not observed in healthy cells. In addition are
the on-cell patch recordings from the RBCs of another R2456H
patient revealing once again an increased cation channel activity
(independent of mechanical stimulation) without information on
the identity of the channel (Shmukler et al., 2014). Consistent
with Piezo 1 increased activity having direct or secondary
effects on membrane conductance is the observed decrease in
conductance in P52.1 (E2496ELE) RBCs. Also in P51.3 and
P51.4 (R2456H) and P52.1 (E2496ELE) a rightward shift of
the I/V curve is observed (Figures 7Bb, 8Bb) indicative of an
upregulation/downregulation of a channel/channels. Whether
the shift is pertinent to the mutations though is not explicitly
clear as such a shift is not detected when patients’ currents are
compared with their transportation controls (Figures 7Ba, 8Ba).
Concerning mutation C426R (P50.2) which shows an increase
in current only with the general control but not with its
transportation control we tend to disregard the difference
shown with the general control as the transportation control
was taken from a genetically related healthy subject and it
indeed shows a remarkable similarity with the I/V curve of the
patient (Figure 8Aa).
Enzymopathies and Beta-Thalassemia
Metabolic enzyme deficiencies (glucose-6-phosphate
dehydrogenase deficiency, pyruvate kinase deficiency, glutamate-
cysteine ligase deficiency and glutathione reductase deficiency)
as well as β-thalassemia are not accompanied by changes in
membrane conductance. The former is consistent with the lack
of changes also in the K+ and Na+ content of 11 patients
with congenital non-spherocytic haemolytic anemia including
pyruvate kinase deficiency (Vives Corrons and Besson, 2001).
CONCLUSION
Trying to summarize and come up with a common channel
increased activity/dysfunction or just an effect (decrease or
increase in conductance) accompanying RBCs ion disbalance
disorders, we stumble upon a great variability in results. Such
a variability is of course reflecting the many triggers of the
disbalance and for sure not lessened by the fact that not only
between different mutations but also among members of a
family with the same mutation there are distinct differences
starting from the severity of the disease and extending down
to the cellular level. Such a summary is even harder and
certainly not helped by the great variability in healthy subjects
reflected in control membrane conductance measurements as
seen in our study. And last but not least answers are yet
heavier without so far clearly knowing how an increased
Na+ and a decreased K+ can lead to overhydration as in
OHSt or to dehydration as in HX. Nevertheless based on
our study we conclude that changes in conductance are
incurred by certain α-spectrin [c.2755G > T (p.Glu919) and
c.678G > A p.(Glu227fs) whenever an αLELY allele is present],
band 3 protein [c.2348T > A p.(Ile783Asn)] and Piezo1
(c.7483_7488dupCTGGAG p.2495_2496dupLeuGlu) mutations
as a difference is observed with both the general and the
transportation control. Identification of the channel/channels
that underlie the changed conductances demands future studies.
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